share_log
Benzinga ·  Apr 30 09:19
NRx Pharmaceuticals Shares Are Trading Lower After the Company Announced Findings From Its Phase 2b/3 Trial of NRX-101 Vs. Lurasidone
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment